ADAMTS18 293T Cell Transient Overexpression Lysate, Novus Biologicals
Bio-Techne includes Novus Biologicals | Catalog # H00170692-T01
Key Product Details
Species
Human
Applications
Western Blot
Product Summary for ADAMTS18 293T Cell Transient Overexpression Lysate
Quality control test: Transient overexpression cell lysate was tested with Anti-ADAMTS18 antibody by Western Blots. Plasmid: pCMV-ADAMTS18 full-length
Product Specifications
Specificity
ADAMTS18 293T Cell Transient Overexpression Lysate(Denatured)
Type
293T Cell Transient Overexpression
Protein State
Denatured
Scientific Data Images for ADAMTS18 293T Cell Transient Overexpression Lysate
ADAMTS18 transfected lysate.
Lane 1: ADAMTS18 transfected lysate (135.1 KDa) Lane 2: Non-transfected lysate.
Formulation, Preparation, and Storage
Formulation
1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
Concentration
mg/ml
Shipping
The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store at -80C. Avoid freeze-thaw cycles.
Background: ADAMTS18
Alternate Names
A disintegrin and metalloproteinase with thrombospondin motifs 18, a disintegrin-like and metalloprotease (reprolysin type) with thrombospondintype 1 motif, 18, a disintegrin-like and metalloprotease (reprolysin type) with thrombospondintype 1 motif, 21, ADAM metallopeptidase with thrombospondin type 1 motif, 18, ADAM-TS 18, ADAM-TS18, ADAMTS-18, ADAMTS21, disintegrin and metalloprotease-like protein, EC 3.4.24.-, EC 3.4.24.82
Gene Symbol
ADAMTS18
Additional ADAMTS18 Products
Product Documents for ADAMTS18 293T Cell Transient Overexpression Lysate
Product Specific Notices for ADAMTS18 293T Cell Transient Overexpression Lysate
This product is produced by and distributed for Abnova, a company based in Taiwan.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Lysates are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...